Concepts (113)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protein Engineering | 5 | 2020 | 77 | 1.570 |
Why?
|
| Biocompatible Materials | 4 | 2022 | 141 | 1.100 |
Why?
|
| Hydrogels | 4 | 2021 | 110 | 1.070 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2022 | 26 | 0.760 |
Why?
|
| Cartilage Oligomeric Matrix Protein | 2 | 2018 | 3 | 0.740 |
Why?
|
| Cartilage, Articular | 1 | 2022 | 73 | 0.720 |
Why?
|
| Chemical Warfare Agents | 1 | 2020 | 4 | 0.710 |
Why?
|
| Enzymes, Immobilized | 1 | 2020 | 15 | 0.700 |
Why?
|
| Organophosphorus Compounds | 1 | 2020 | 31 | 0.690 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 47 | 0.690 |
Why?
|
| Proteins | 3 | 2020 | 730 | 0.670 |
Why?
|
| Osteoarthritis | 1 | 2022 | 131 | 0.670 |
Why?
|
| Pesticides | 1 | 2020 | 55 | 0.650 |
Why?
|
| Protein Domains | 3 | 2019 | 140 | 0.620 |
Why?
|
| Nanocomposites | 1 | 2018 | 26 | 0.570 |
Why?
|
| Cellulase | 1 | 2017 | 5 | 0.550 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2017 | 11 | 0.550 |
Why?
|
| Nanoconjugates | 1 | 2017 | 5 | 0.550 |
Why?
|
| Peptides | 1 | 2020 | 549 | 0.530 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 490 | 0.480 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 1 | 2013 | 9 | 0.440 |
Why?
|
| Integrin beta3 | 1 | 2013 | 5 | 0.440 |
Why?
|
| src Homology Domains | 1 | 2013 | 20 | 0.440 |
Why?
|
| Monascus | 2 | 2022 | 2 | 0.390 |
Why?
|
| Melanoma | 2 | 2023 | 318 | 0.320 |
Why?
|
| Models, Molecular | 3 | 2020 | 1128 | 0.320 |
Why?
|
| Doxorubicin | 2 | 2019 | 97 | 0.290 |
Why?
|
| Polymers | 2 | 2022 | 316 | 0.280 |
Why?
|
| Drug Carriers | 2 | 2019 | 175 | 0.260 |
Why?
|
| Protein Conformation | 2 | 2020 | 763 | 0.260 |
Why?
|
| Amino Acid Sequence | 2 | 2020 | 1553 | 0.240 |
Why?
|
| RNA, Small Interfering | 2 | 2024 | 857 | 0.240 |
Why?
|
| Histidine | 1 | 2024 | 34 | 0.220 |
Why?
|
| Liposomes | 1 | 2024 | 100 | 0.220 |
Why?
|
| Oligopeptides | 1 | 2024 | 128 | 0.220 |
Why?
|
| Tertiary Lymphoid Structures | 1 | 2023 | 4 | 0.210 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 45 | 0.200 |
Why?
|
| Gels | 1 | 2022 | 64 | 0.190 |
Why?
|
| Rabbits | 1 | 2022 | 322 | 0.180 |
Why?
|
| Chemical Phenomena | 1 | 2020 | 94 | 0.170 |
Why?
|
| Hydrolysis | 1 | 2020 | 140 | 0.170 |
Why?
|
| Catalysis | 1 | 2020 | 152 | 0.170 |
Why?
|
| Structure-Activity Relationship | 1 | 2020 | 365 | 0.160 |
Why?
|
| Theranostic Nanomedicine | 1 | 2019 | 6 | 0.160 |
Why?
|
| Recombinant Proteins | 2 | 2019 | 689 | 0.160 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2019 | 31 | 0.160 |
Why?
|
| Elastin | 1 | 2018 | 10 | 0.150 |
Why?
|
| Elasticity | 1 | 2018 | 40 | 0.150 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 651 | 0.150 |
Why?
|
| Spectrum Analysis | 1 | 2018 | 51 | 0.140 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2022 | 164 | 0.140 |
Why?
|
| Microscopy, Confocal | 1 | 2018 | 226 | 0.140 |
Why?
|
| Protein Multimerization | 1 | 2018 | 169 | 0.140 |
Why?
|
| Enzyme Stability | 1 | 2017 | 46 | 0.140 |
Why?
|
| Polyethylene Glycols | 1 | 2017 | 165 | 0.120 |
Why?
|
| Gold | 1 | 2018 | 225 | 0.120 |
Why?
|
| Drug Delivery Systems | 1 | 2019 | 312 | 0.120 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 182 | 0.120 |
Why?
|
| Gene Expression | 1 | 2018 | 809 | 0.120 |
Why?
|
| Anti-Allergic Agents | 1 | 2014 | 2 | 0.110 |
Why?
|
| Reishi | 1 | 2014 | 2 | 0.110 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2014 | 9 | 0.110 |
Why?
|
| Hypersensitivity | 1 | 2014 | 63 | 0.110 |
Why?
|
| Circular Dichroism | 1 | 2013 | 107 | 0.110 |
Why?
|
| Protein Binding | 2 | 2018 | 1555 | 0.100 |
Why?
|
| Tyrosine | 1 | 2013 | 92 | 0.100 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2013 | 111 | 0.100 |
Why?
|
| Molecular Docking Simulation | 1 | 2013 | 73 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2019 | 493 | 0.100 |
Why?
|
| Escherichia coli | 1 | 2017 | 695 | 0.100 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 628 | 0.100 |
Why?
|
| Protein Structure, Secondary | 2 | 2024 | 253 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 220 | 0.100 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 656 | 0.090 |
Why?
|
| Humans | 9 | 2024 | 59366 | 0.090 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 737 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 883 | 0.090 |
Why?
|
| Micelles | 2 | 2019 | 80 | 0.070 |
Why?
|
| MCF-7 Cells | 2 | 2019 | 65 | 0.070 |
Why?
|
| Animals | 3 | 2022 | 19649 | 0.070 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 256 | 0.070 |
Why?
|
| Temperature | 2 | 2019 | 295 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2023 | 35 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 26 | 0.050 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2023 | 98 | 0.050 |
Why?
|
| Transfection | 1 | 2024 | 675 | 0.050 |
Why?
|
| Pigments, Biological | 1 | 2021 | 7 | 0.050 |
Why?
|
| Pigmentation | 1 | 2021 | 25 | 0.050 |
Why?
|
| Adjuvants, Immunologic | 1 | 2023 | 224 | 0.050 |
Why?
|
| Fermentation | 1 | 2021 | 42 | 0.050 |
Why?
|
| Rheology | 1 | 2021 | 71 | 0.050 |
Why?
|
| Superoxide Dismutase | 1 | 2022 | 213 | 0.040 |
Why?
|
| Plant Extracts | 1 | 2022 | 163 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2023 | 551 | 0.040 |
Why?
|
| Antioxidants | 1 | 2022 | 241 | 0.040 |
Why?
|
| Tissue Engineering | 1 | 2021 | 134 | 0.040 |
Why?
|
| Fluorine | 1 | 2019 | 9 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2019 | 111 | 0.040 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2019 | 62 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2023 | 941 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2019 | 55 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2019 | 258 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2023 | 986 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2018 | 110 | 0.040 |
Why?
|
| Amino Acid Motifs | 1 | 2018 | 149 | 0.040 |
Why?
|
| Biomarkers | 1 | 2023 | 1306 | 0.030 |
Why?
|
| Lipids | 1 | 2017 | 300 | 0.030 |
Why?
|
| Patents as Topic | 1 | 2014 | 7 | 0.030 |
Why?
|
| Immunomodulation | 1 | 2014 | 28 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2019 | 2052 | 0.020 |
Why?
|
| Mice | 1 | 2019 | 10294 | 0.020 |
Why?
|
| Male | 1 | 2022 | 27742 | 0.010 |
Why?
|
| Female | 1 | 2019 | 30719 | 0.010 |
Why?
|